Patent classifications
C
C12
C12N
2720/00
C12N2720/00011
C12N2720/12011
C12N2720/12111
C12N2720/12132
C12N2720/12132
Epizootic hemorrhagic disease virus—tel aviv university (EHDV-TAU)—oncolytic virus for treating cancer
11484558
·
2022-11-01
·
·
The present invention relates to a unique oncolytic virus, Epizootic Hemorrhagic Disease virus-Tel Aviv University (EHDV-TAU), and to methods and pharmaceutical compositions comprising thereof for preventing or treating cancer exhibiting an alteration in interferon signaling and/or the innate immune antiviral response.
EPIZOOTIC HEMORRHAGIC DISEASE VIRUS - TEL AVIV UNIVERSITY (EHDV-TAU) - ONCOLYTIC VIRUS FOR TREATING CANCER
The present invention relates to a unique oncolytic virus, Epizootic Hemorrhagic Disease virus-Tel Aviv University (EHDV-TAU), and to methods and pharmaceutical compositions comprising thereof for preventing or treating cancer exhibiting an alteration in interferon signaling and/or the innate immune antiviral response.